iScience Interventional Corp Obtains $2,000,000 Series F Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cd14e7de-098a-4bcb-bd79-e1806975a8ce&Preview=1 -
Date
4/21/2009 -
Company Name
iScience Interventional Corp -
Mailing Address
4055 Campbell Avenue Menlo Park, CA 94025 -
Company Description
iScience Interventional™ discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies.
This new category of therapy is called Interventional Ophthalmology. It encompasses microcatheter-based therapies designed to access a wide range of anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. -
Website
http://www.iscienceinterventional.com/ -
Transaction Type
Venture Equity -
Transaction Amount
$2,000,000 -
Transaction Round
Series F -
Proceeds Purposes
The additional funding will enable iScience to build upon its unique position in the marketplace, continue commercial activities for glaucoma and develop further applications for treatments in the eye. -
M&A Terms
-
Venture Investor
L Capital Partners -
Venture Investor
Affinity Venture Group -
Venture Investor
Johnson & Johnson Development Corporation -
Venture Investor
Clarian Health Ventures
